Antithrombin Market to reach US$ 725.2 Mn by 2026, exhibiting a CAGR of 4.1%. | Fortune Business Insights

NEXT STORY
Meningococcal Vaccines Market Revenue is Expected to Reach worth US$ 6.5 billion by 2029 – PMR
PREV STORY
GeoVax Presents HIV Vaccine Study Data
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Cocrystal Pharma Announces New Data on CC-31244 and Abstract Acceptance for Poster Presentation at the AASLD 2019 Liver Meeting

author_avatar
NASDAQ Market News

MeMed Receives CE Mark for Two Pioneering Technologies: The MeMed BV™ Test and MeMed Key™ Point-of-Need Platform

author_avatar
NASDAQ Market News

Zai Lab Announces First Patient Dosed in China in a Global Phase 3 Study of Retifanlimab in Patients with NSCLC

author_avatar
NASDAQ Market News